Who owns IMMIX BIOPHARMA INC?
- Ticker: IMMX
- CUSIP Number: 45258h106
Tip: Access positions for across all investors
Analyze quarterly positions in Immix Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Immix Biopharma stock
Who bought or sold IMMIX BIOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Bleichroeder | 850k | $1.8M | 0% | Sep 2025 |
|
| Vanguard Group | 730k | $1.5M | 5% | Sep 2025 |
|
| Geode Capital Management | 188k | $392k | 16% | Sep 2025 |
|
| Morgan Stanley | 125k | $259k | 100% | Jun 2025 |
|
| State Street Corporation | 99k | $207k | 130% | Sep 2025 |
|
| Susquehanna International | 91k | $190k | 79% | Sep 2025 |
|
| Citadel Advisors | 90k | $188k | 100% | Sep 2025 |
|
| Northern Trust | 89k | $187k | -5% | Sep 2025 |
|
| United Capital Financial Advisers | 71k | $148k | 100% | Sep 2025 |
|
| Imprint Wealth | 67k | $141k | 100% | Sep 2025 |
|
| Marshall Wace | 55k | $115k | 100% | Sep 2025 |
|
| BlackRock | 43k | $90k | 7% | Sep 2025 |
|
| Tocqueville Asset Management | 40k | $84k | 37% | Sep 2025 |
|
| XTX Topco | 35k | $74k | 100% | Sep 2025 |
|
| Velan Capital Investment Management | 35k | $73k | 40% | Sep 2025 |
|
| Private Advisor | 31k | $65k | 0% | Sep 2025 |
|
| Tritonpoint Wealth | 25k | $51k | 0% | Sep 2025 |
|
| Renaissance Technologies | 22k | $45k | 100% | Sep 2025 |
|
| SBI Securities | 18k | $37k | 0% | Sep 2025 |
|
| Commonwealth Equity Services | 16k | $34k | 0% | Sep 2025 |
|
| Jane Street | 15k | $31k | 100% | Sep 2025 |
|
| Colony | 12k | $25k | 0% | Sep 2025 |
|
| Snowden Capital Advisors | 10k | $21k | 100% | Sep 2025 |
|
| Atlantic Trust | 10k | $21k | 100% | Sep 2025 |
|
| MAI Wealth Advisors | 2.0k | $4.2k | 100% | Sep 2025 |
|
| UBS Group | 1.9k | $4.1k | -86% | Sep 2025 |
|
| Wells Fargo & Company | 330.00 | $689.997000 | 0% | Sep 2025 |
|
| Northwestern Mutual Wealth Management Company | 80.00 | $167.000000 | 0% | Sep 2025 |
|
| SRS Capital Advisors | 34.00 | $70.998800 | 100% | Sep 2025 |
|
Who sold out of Immix Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Virtu Financial | Jun 2025 | 18k | $37k |
| FNY Investment Advisers | Mar 2025 | 11k | $18k |
| Royal Bank of Canada | Jun 2025 | 11k | $23k |
| Raymond James Financial | Jun 2025 | 525.00 | $1.1k |
| Tower Research Capital | Jun 2025 | 131.00 | $270.999700 |
| Jpmorgan Chase & Co | Mar 2025 | 35.00 | $58.999500 |